Research Article
Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking
Table 2
The binding energy and interactions of ingredients bound to key targets.
| ID | Ingredient | Bind energy (kcal/mol) | AKT1 | TNF | MAPK8 |
| MOL000098 | Quercetin | −9.4 | −6.1 | −7.5 | MOL000422 | Kaempferol | −7.1 | −6.4 | −7.4 | MOL000449 | Stigmasterol | −5.7 | −5.3 | −7.2 | MOL000546 | Diosgenin | −7.1 | −5.4 | −8.8 | MOL008457 | Tetrahydroalstonine | −6.4 | −6.3 | −7.0 |
|
|